Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-22Endoscopic Gastric Mucosal Ablation (GMA) as a Primary Obesity Therapy Early Feasibility [COMET EF] - Step II
-
CLINICAL_TRIALS study record update · 2026-01-22A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study of Once-Weekly Tirzepatide Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
-
CLINICAL_TRIALS study record update · 2026-01-22Current Status of Cardiovascular Diseases in Chinese Overweight/ Obesity Population: An Epidemiological Study (COPE）
-
CLINICAL_TRIALS study record update · 2026-01-22Efficacy and Safety of Oral Semaglutide 50 mg Once Daily in Chinese Adults With Overweight or Obesity (OASIS 3)
-
CLINICAL_TRIALS study record update · 2026-01-22Safety and Feasibility of HybridAPC for Gastric Mucosal Ablation in the Management of Patients With Class III Obesity
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-21Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy
-
CLINICAL_TRIALS study record update · 2026-01-21Comparing the Efficacy and Safety of the EndoZipTM System and Apollo Endoscopic Sleeve Gastroplasty (ESG), Followed by Behavioral Modifications, in Obese Patients Who Have Not Achieved Weight Reduction Through Non-surgical Methods.
-
CLINICAL_TRIALS study record update · 2026-01-21Optimizing Just-in-Time Adaptive Intervention to Improve Dietary Adherence in Behavioral Obesity Treatment: A Micro-randomized Trial
-
CLINICAL_TRIALS study record update · 2026-01-21Enhancing Mental and Physical Health of Women Through Engagement and Retention (EMPOWER) 3.0 (QUE 25-015)
-
CLINICAL_TRIALS study record update · 2026-01-21A Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-01-21Developing a Behavioral Weight Loss Intervention for Emerging Adults Implemented Within College Health Service Centers
-
CLINICAL_TRIALS study record update · 2026-01-21Identification of Factors Predictive of the Efficacy of Endoscopic Endoscopic Sleeve Gastroplasty & Study the Evolution of Clinical, Biological and Intestinal Intestinal Microbiota After Surgery
-
CLINICAL_TRIALS study record update · 2026-01-21Efficacy and Safety of Ixekizumab or Ixekizumab Concomitantly Administered With Tirzepatide in Adult Participants With Active Psoriatic Arthritis and Obesity or Overweight: A Phase 3b, Randomized, Multicenter, Open-Label Study (TOGETHER-PsA)
-
CLINICAL_TRIALS study record update · 2026-01-21Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization. A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-01-21Smallest Significant Value in Osteodensitomery in an Obese Population
-
CLINICAL_TRIALS study record update · 2026-01-20Efficacy and Safety of Ixekizumab or Ixekizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight: A Phase 3b, Randomized, Multicenter, Open-Label Study (TOGETHER-PsO)
-
CLINICAL_TRIALS study record update · 2026-01-20Reversing the Negative Cardiovascular Effects of Weight (ReNEW) Clinic Cohort Study
-
CLINICAL_TRIALS study record update · 2026-01-20A Dose-Escalation Phase 1, Investigator- and Participant-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of LY3532226 in Participants With Obesity
-
CLINICAL_TRIALS study record update · 2026-01-20Investigating Fitness Interventions in the Elderly (INFINITE)
-
CLINICAL_TRIALS study record update · 2026-01-20A Multiple-Ascending Dose Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of LY3537031 in Overweight and Obese Participants and Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2026-01-20Long-term Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema 2.4 mg/2.4 mg) Once Weekly Versus Placebo in Participants With Obesity
-
CLINICAL_TRIALS study record update · 2026-01-20Obesity Stigma and Health Behavior: An Experimental Approach
-
CLINICAL_TRIALS study record update · 2026-01-20The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment
-
CLINICAL_TRIALS study record update · 2026-01-20A Phase 2 Randomized, Placebo-controlled, Double-blind, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2026-01-16A Phase I, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Subcutaneous Administration of Single Ascending Doses of HRS-5817 in Obese Participants